Show results for
Refine by
Coronary Disease Suppliers Serving Canada
54 companies found
based inRedondo Beach, CALIFORNIA (USA)
Quantimetrix designs, develops, and manufactures laboratory quality products at our headquarters in Redondo Beach, California. We are leaders in the field of liquid-stable quality control products, having pioneered these innovations more than 40 ...
based inIrvine, CALIFORNIA (USA)
CathWorks is the leader in digital health innovations that can improve the lives of patients globally. The CathWorks FFRangio System combines advanced computational science and artificial intelligence, transforming how cardiovascular disease is ...
based inChangsha, CHINA
Sinocare has 20 years experiences in BGM industry since its foundation in 2002, it is the biggest BGM manufacturing facility company in Asia and the first listed blood glucose meter manufacturer company in China, dedicating to the innovation of ...
The PalmLab® (Model: SLX-120&SLX-121): Lipid and Blood Glucose Monitoring System is for the quantitative measurement of total cholesterol(TC), high density lipoprotein(HDL) cholesterol, triglycerides(TG), and glucose(GLU). A Chol/HDL ratio ...
based inDulles, VIRGINIA (USA)
We are dedicated to improving patient outcomes by developing, supplying and delivering molecular diagnostics and therapeutics (theranostics). The early vision for molecular imaging was to revolutionize clinical diagnostics and therapeutics to better ...
Neuraceq is a radioactive diagnostic agent indicated for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for ...
based inBonn, GERMANY
CARDIONOVUM, a medical technology company based in Bonn, Germany, develops and commercializes innovative medical devices such as the new generation of DCB and drug-eluting stents for the treatment of coronary and peripheral artery disease. The ...
Unmatched XLIMUS clinical performance. The ultimate DES for complex artery lesions. XLIMUS is considered as the ultimate coronary DES stent system to treat complex coronary artery disease by ...
based inErlangen, GERMANY
Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. We expand ...
The healthcare market is driven by the need to enhance efficiency and efficacy. Delivering on both, minimally invasive image-guided therapies are changing the way healthcare can be provided. And the market is growing: The global population aged 60 ...
based inBedford, MASSACHUSETTS (USA)
Infraredx, a Nipro company, is an intravascular imaging company committed to advancing the diagnosis and management of coronary artery disease around the world. We harness 30 years of research into the association between heart attacks and lipid ...
based inEpalinges, SWITZERLAND
Novostia is a privately held medical device company developing an innovative artificial heart valve, especially for young patients. With the support of world leading surgeons, Novostia endeavors to improve the quality of life of millions of patients ...
based inIrvine, CALIFORNIA (USA)
Endologix LLC is a California-based, global medical device company dedicated to improving patients’ lives by providing innovative therapies for the interventional treatment of vascular disease. With a robust pipeline of disruptive technology, our ...
The U.S. Preventative Services Task Force and the American Academy of Family Physicians recommend AAA screening ...
based inGhislenghien, BELGIUM
DiAgam produces turbidimetric immuno reagents. We are active in the field of Biotechnology. Our R&D department aims its work to developing classical immunology technologies as well as new and innovative technologies based on nanobiotechnologies. ...
C-reactive protein (CRP) is an α1-globulin predominantly synthesized by hepatocytes. It consists of five identical non-glycosylated polypeptide subunits, linked together non-covalently, forming a protein of about 115 kDa. It is composed of few ...
based inPoway, CALIFORNIA (USA)
Diazyme uses its proprietary enzyme technologies to develop diagnostic reagents which can be used on most automated chemistry analyzers in user-friendly formats. Diazyme's products include test kits for diagnosis of cardiovascular disease, liver ...
Diazyme's LDL-Cholesterol Assay is a direct dual liquid stable reagent system. Reagent transfer is eliminated for most chemistry systems with a choice of convenient instrument specific packaging options including Roche™ Hitachi 917 series, ...
based inMonroe Township, NEW JERSEY (USA)
We are a multinational company active in the life science sector, a world leader in imaging diagnostics. Every day we seek and perfect increasingly advanced and sustainable techniques and solutions to open new paths in diagnostic imaging. So that ...
Interventional cardiology is a subspecialty of cardiology that utilizes non-surgical, catheter-based procedures to treat all sorts of heart diseases, such as narrowed arteries, damaged or weakened blood vessels, heart valve disorders, and congenital ...
based inCarlsbad, CALIFORNIA (USA)
CeloNova BioSciences, Inc. is developer and manufacturer of a portfolio of novel surfaced coated technologies, including the proprietary Polyzene-F nanocoating. This next-generation nanocoating is the result of years of rigorous scientific research ...
Our proprietary COBRA SG drug-coated PTCA balloon includes a bio-active medical coating designed to improve adhesion of organic and inorganic substrates and optimize drug delivery. Developed at a leading, international medical university, the novel ...
based inSão Paulo, BRAZIL
We were born on July, 15, 1994 in Amparo/SP, and the essence of our company is to use state-of -the-art technology to develop equipment for human wellness, in physical rehabilitation, esthetics or esthetic medicine. Today, we are located in a built ...
based inWuxi, CHINA
CHISON Medical Technologies Co., LTD has emerged as World’s leading Diagnostic Ultrasound manufacturer since its inception in 1996. In the journey of constant development and revolution in technologies, CHISON has set its foot independently with ...
A revolutionary invention with everything you can imagine makes you more ...
based inSan Diego, CALIFORNIA (USA)
Everyone at AnaBios shares a passion and commitment to make a difference in the development of promising new therapies and cures for patients by reducing the time and expense needed to bring these medicines to patients. We do this by generating ...
The human heart is a complex organ of distinct sub-structures, different tissue types and cellular architectures that work in a coordinated fashion to pump blood throughout the body (Figure 1). Tissue distribution, cellular composition and gene ...
based inHorsholm, DENMARK
At TannerMedico A/S, our aim is to help you sleep comfortable, breathe easier and live healthier. We truly believe that any good treatment aims at killing the cause and not just the symptoms. We are a Scandinavian company with the corporate ...
based inMont-Saint-Guibert, BELGIUM
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution platform is based on the Genio® system, a CE-Mark validated, ...
Genio is the disruptive sleep apnea solution for patients who suffer from moderate to severe Obstructive Sleep Apnea or OSA. Genio is the world’s first and unique battery-free, leadless, full body MR conditional and minimally invasive ...
based inLeiden, NETHERLANDS
Medis was created in 1989 as a spin-off of the Leiden University Medical Centre (LUMC Netherlands). Our founder and current CSO, Hans Reiber, built the company focusing on X-ray and image analysis of the heart with the mission to make these tools ...
The innovative, vendor-independent post-processing software solution for advanced quantitative analysis of cardiovascular CT ...
based inSan Rafael, CALIFORNIA (USA)
Established in 1997, BioMarin is a world leader in developing and commercializing first- or best-in-class therapies for rare genetic diseases. We take pride in going where the science leads us, pioneering breakthrough treatments for debilitating and ...
ALDURAZYME (laronidase) is indicated for patients with Hurler and Hurler-Scheie forms of mucopolysaccharidosis I (MPS I) and for patients with the Scheie form who have moderate to severe symptoms. The risks and benefits of treating mildly affected ...